North Carolina Veterinary School HCM Clinical Trial for Cats

 

Details on the North Carolina College of Veterinary Medicine Hypertrophic Cardiomyopathy study for cats

Principal Investigator

Kathryn Meurs

Testing Requirements

This is a placebo-controlled clinical trial that evaluates the effect of novel drug therapy (rapamycin) in cats with hypertrophic cardiomyopathy (HCM). Rapamycin has shown in rats and humans to reverse the progression of HCM. The clinical trial requires four visits over a 6 month period. During the period owners must be willing to come to NC State University Veterinary Hospital, give medication by mouth once weekly, and complete questionnaires.

Enrollment Start

01/25/2021

Enrollment Finish

01/12/2022

Eligibility

-Cats diagnosed with HCM must otherwise be healthy

-Cats must be less than 12 years old

-Cats must be greater than 7.7lbs

Exclusions

Cats with the following:

-Congestive heart failure

-Hypertension

-Chronic Kidney Disease

-Anemia

-On chronic medication that alters cardiac function

****

Financial Incentive

FULLY FUNDED! – this includes recheck cardiology exams, echocardiograms, chest x-rays, bloodwork, blood pressure measurement, and echocardiograms

Contact

Ashley Fuhrer: 919 515-3634 OR cvmclinicalstudies@ncsu.edu

See the attached flyer for more details

HCM-flyer updated May 2021

You can also visit the NC State Veterinary College website for further details below

Clinical Trials List

Share on facebook
Facebook
Share on google
Google+
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest